Viola K. Detemple
Minden, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A composite score of serum cytokines enables early identification of patients at high risk for irAEs under immune checkpoint inhibition.
Journal: Frontiers in immunology
Published: October 27, 2025
Alcian blue-positive stromal phenotype in basal cell carcinoma is associated with progression on first-line hedgehog inhibitors.
Journal: The journal of pathology. Clinical research
Published: October 22, 2025
Real-world experience with first- versus second-line cemiplimab for advanced basal cell carcinoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 24, 2025
Machine learning-derived serum protein signatures as biomarkers for checkpoint inhibition in melanoma.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: April 14, 2025
Anti-tumor effects of tirbanibulin in squamous cell carcinoma cells are mediated via disruption of tubulin-polymerization.
Journal: Archives of dermatological research
Published: April 25, 2024
Short- and long-term immunosuppressive effects of melanoma influence the prognostic value of the sentinel lymph node status.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 19, 2024
S2k-Leitlinie - Merkelzellkarzinom - Update 2022.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: May 20, 2022
S2k Guideline - Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) - Update 2022.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: May 20, 2022
Effects of mammalian target of rapamycin inhibitors on cytokine production and differentiation in keratinocytes.
Journal: Experimental dermatology
Published: May 05, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026